Article Versions Notes

Ratliff M, Kim H, Qi H, Kim M, Ku B, Azorin DD, Hausmann D, Khajuria RK, Patel A, Maier E, et al. Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma. International Journal of Molecular Sciences. 2022; 23(12):6572. https://doi.org/10.3390/ijms23126572

Ratliff, Miriam, Hichul Kim, Hao Qi, Minsung Kim, Bosung Ku, Daniel Dominguez Azorin, David Hausmann, Rajiv K. Khajuria, Areeba Patel, Elena Maier, and et al. 2022. "Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma" International Journal of Molecular Sciences 23, no. 12: 6572. https://doi.org/10.3390/ijms23126572

Ratliff, M., Kim, H., Qi, H., Kim, M., Ku, B., Azorin, D. D., Hausmann, D., Khajuria, R. K., Patel, A., Maier, E., Cousin, L., Ogier, A., Sahm, F., Etminan, N., Bunse, L., Winkler, F., El-Khoury, V., Platten, M., & Kwon, Y.-J. (2022). Patient-Derived Tumor Organoids for Guidance of Personalized Drug Therapies in Recurrent Glioblastoma. International Journal of Molecular Sciences, 23(12), 6572. https://doi.org/10.3390/ijms23126572